Mark Harrison
Impact in
- Oncology top 2%
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
-
- Gastric Cancer Management and Outcomes
Papers in
- Co-authors
- Rob Glynne‐Jones (33 shared papers)Richard Adams (9 shared papers)David Sebag‐Montefiore (10 shared papers)Neel J. Bhuva (3 shared papers)Andreas Makris (3 shared papers)J. Grainger (3 shared papers)Maria Andreia Hawkins (12 shared papers)Rebecca Muirhead (10 shared papers)
- Journals
- Annals of Oncology (8 papers)The Lancet Oncology (7 papers)Clinical Oncology (7 papers)International Journal of Radiation Oncology*Biology*Physics (6 papers)Radiotherapy and Oncology (4 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Mark Harrison
62 papers receiving 2.4k citations
Mark Harrison's Hit Papers
Peers
Comparison fields: 5 of 69
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 443
- Surgery 576
- Radiation 71
- Cancer Research 63
Countries citing papers authored by Mark Harrison
This map shows the geographic impact of Mark Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Harrison more than expected).
Fields of papers citing papers by Mark Harrison
This network shows the impact of papers produced by Mark Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Harrison. The network helps show where Mark Harrison may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Harrison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 327 | |
| 2 | Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial Hit paper breakdown → | 2014 | 270 |
| 3 | 2014 | 232 | |
| 4 | 2018 | 142 | |
| 5 | 2014 | 109 | |
| 6 | 2017 | 106 | |
| 7 | 2005 | 105 | |
| 8 | 2005 | 89 | |
| 9 | 2013 | 81 | |
| 10 | 2006 | 79 | |
| 11 | 2012 | 72 | |
| 12 | 2010 | 63 | |
| 13 | 2010 | 48 | |
| 14 | 2012 | 48 | |
| 15 | 2016 | 48 | |
| 16 | 2018 | 45 | |
| 17 | 2012 | 43 | |
| 18 | 2014 | 38 | |
| 19 | 2016 | 38 | |
| 20 | 2007 | 37 |
About Mark Harrison
Mark Harrison is a scholar working on Oncology, Surgery, Radiation, Pulmonary and Respiratory Medicine and Economics and Econometrics, having authored 65 papers that have together received 2.5k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (25 papers), Colorectal and Anal Carcinomas (14 papers), Colorectal Cancer Treatments and Studies (13 papers), Advanced Radiotherapy Techniques (7 papers), Esophageal Cancer Research and Treatment (4 papers), Pancreatic and Hepatic Oncology Research (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Oncology (1.2k citations), Pulmonary and Respiratory Medicine (443 citations), Surgery (576 citations), Radiation (71 citations) and Cancer Research (63 citations). Mark Harrison has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Rob Glynne‐Jones, Richard Adams, David Sebag‐Montefiore, Neel J. Bhuva, Andreas Makris, J. Grainger, Maria Andreia Hawkins, Rebecca Muirhead, Duncan Charles Gilbert and Mark P. Saunders. Their work appears in journals such as Annals of Oncology, The Lancet Oncology, Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.